IPRC is a privately owned
leading Clinical Research Organization (CRO), established by Prof. Naji Najib in 1997 to provide clinical & bioanalytical services for the pharmaceutical industry.
IPRC has successfully passed numerous inspections
by US-FDA, EMA, WHO and is accredited by the Turkish MOH. IPRC is approved by the
Jordan Food and Drug Administration as well by the Gulf Cooperation Council
IPRC has a fully-equipped clinic and bioanalytical facilities under the same roof. With 60 beds, the main facility is well-suited for mid-sized BE studies. The Bioanalytical laboratory has processed hundreds of thousands of samples and is complete with state-of-the-art LCMSMS stations managed by Watson LIMSTM adhring to international standards.
In accordance with ICH-GCP regulations, IPRC provides quality research
- Phase I bioavailability/bioequivalence/pharmacokinetics studies
- Clinical trials management, phase II-IV throughout the MENA region
- Data management, PK, statistics & medical writing
With more than 100 professionals, IPRC has conducted more than 1000 bioequivalence, bioavailability and pharmacokinetics studies catered to US, EU,
and MENA markets. IPRCís reports are accepted by US-FDA, EMA and other Regulatory